🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific action to address cost of living pressures" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that lowering inflation is a shared duty of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven developed nations this calendar year and next.

Potential Energy Cost Measures

Reports indicate the administration could take action to lower energy bills, such as by cutting the current 5% rate of value-added tax applied on energy supplies.

An additional approach is to lower some of the policy costs currently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will obtain the latest draft from the official forecaster, the OBR, on the start of the week, which will clarify how much room there is for these measures.

The expectation from most experts is that the Chancellor will have to announce higher taxes or budget cuts in order to fulfill her declared debt limits.

Earlier on Thursday, analysis showed there was a twenty-two billion pound deficit for the chancellor to resolve, which is at the more modest range of expectations.

"It is a joint task between the central bank and the administration to continue tackling some of the sources of inflation," Reeves told the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Pledges and Global Issues

While much of the attention has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not changed her vow to election pledges not to raise rates on income tax, VAT or National Insurance.

She blamed an "unpredictable world" with growing geopolitical and trade tensions for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

Global Economic Tensions

Addressing concerns about the UK's commercial links with China she said: "Our national security always are paramount."

Last week's statement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are key for advanced tech production led US President Donald Trump to suggest an additional 100% import tax on imports from China, raising the prospect of an full-scale trade war between the two global powers.

The American finance chief labeled the Chinese decision "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to join its battle with the Asian nation, Reeves said she was "deeply worried" by China's measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the action was "damaging for the global economy and creates further headwinds."

"In my view there are areas where we need to challenge Chinese policies, but there are also important opportunities to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also stated she was collaborating with other major economies "regarding our own critical minerals strategy, so that we are less reliant."

NHS Drug Costs and Funding

Reeves also admitted that the price the NHS spends on drugs could increase as a consequence of current discussions with the Trump administration and its drugs companies, in return for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning operations in the UK, with several attributing the modest returns they are receiving.

Recently, the government science advisor said the cost the health service pays for drugs would have to increase to halt companies and drug research funding leaving the United Kingdom.

The Chancellor stated to media: "We have seen because of the pricing regime, that medical research, new drugs have not been available in the UK in the way that they are in other continental states."

"The objective is to guarantee that patients getting care from the National Health Service are able to access the finest essential drugs in the globe. And so we are reviewing this situation, and... aiming to secure additional investment into Britain."